$1.58
0.053.27%
At close: -
$1.54
-0.04-2.53%
After Hours: 4:46 PM EDT
Heron Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Heron Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.03 | $-0.03 | 0.00 % |
Jun 2024 | 2024-08-06 | $-0.06 | $-0.04 | -50.0 % |
Mar 2024 | 2024-05-07 | $-0.02 | $-0.09 | 77.8 % |
Dec 2023 | 2024-03-12 | $-0.07 | $-0.16 | 56.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $32.81M | $36.93M | -11.2 % |
Jun 2024 | 2024-08-06 | $36.02M | $35.89M | 0.37 % |
Mar 2024 | 2024-05-07 | $34.67M | $32.80M | 5.70 % |
Dec 2023 | 2024-03-12 | $34.23M | $30.97M | 10.5 % |
Heron Therapeutics (HRTX) is scheduled to report earnings on March 11, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.03, which hit the estimate of $-0.03.
The Actual Revenue was $32.8M, which missed the estimate of $36.9M.
Browse earnings estimates, EPS, and revenue on all stocks.